• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Home

Pulmonary Hypertension Team

Pulmonary Hypertension

Pulmonary Hypertension RN is an educational resource for patients, caregivers, friends, and family members interested in learning about PAH.   It is an exciting time for the pulmonary hypertension community because new pathways to treat the disease and new treatments are being researched and approved by the FDA (Food and Drug Administration).  Prior to 1996, there were no specific therapies approved to treat PAH.   Without treatment many pulmonary hypertension patients experienced rapid progression of their disease and eventually death.  Since then, the FDA has approved several treatments to slow down the progression of the disease and improve quality of life.  Unfortunately, due to a lack of awareness about PAH patients continue to be misdiagnosed or not treated. 

Jeremy Feldman, MD has devoted his career to treating patients with pulmonary arterial hypertension and has developed this resource to help educate the community and provide the most up to date information on treating pulmonary arterial hypertension.

This site provides information on:

  • Pulmonary arterial hypertension definition
  • Symptoms of pulmonary hypertension
  • Causes of pulmonary hypertension
  • Pulmonary arterial  hypertension diagnosis
  • Treatment for pulmonary hypertension
  • Chronic thromboembolic pulmonary hypertension

All information is edited by an MD and RN (Registered Nurse) specializing in pulmonary hypertension.

Latest from Our Blog

New PAH Drug Ralinepag Shows Exciting Results in Major Study

By Dr. Jeremy Feldman

There is exciting news for people living with pulmonary arterial hypertension (PAH). A new medication called ralinepag has shown strong results in a large clinical trial. PAH is a serious disease that causes high blood pressure in the blood vessels of the lungs. Over time, this makes the heart work harder and can lead to heart failure. […]

Making Order from Chaos

By Dr. Jeremy Feldman

For the first time in my three decades in medicine, the federal government is no longer to be trusted with respect to medical advice.  This creates a confusing mess for patients looking to make good decisions.  In an unprecedented situation, medical organizations have come out strongly contradicting the bogus messaging coming from the current federal administration.  For patients […]

Sotatercept: ZENITH and HYPERION Trials

By Dr. Jeremy Feldman

Sotatercept, the newest drug approved to treat pulmonary arterial hypertension (PAH) has been on the market Since May of 2024.  In the phase 2 PULSAR trial and phase 3 STELLAR trial, sotatercept delivered impressive results, lowering pulmonary artery pressures, improving exercise capacity and leading to improvement in risk status and improved right heart function.   Merck recently […]

In Memoriam:  Greg Ahearn, MD

By Dr. Jeremy Feldman

The pulmonary hypertension community lost a Giant today.   I met Dr. Ahearn in the end of 2003.  He was leaving Duke where he had trained and was working as an attending physician on the pulmonary hypertension team.  He and I were moving to Phoenix to join a small pulmonary group named Arizona Pulmonary Specialists.  We started in the first […]

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH Caregiver

Pulmonary Hypertension Caregiver Burnout

By Dr. Jeremy Feldman

Pulmonary Arterial Hypertension is a rare a debilitating disease. People with the disease have “good days” and “bad

stimulant drugs associated with pulmonary arterial hypertension

Stimulant Associated Pulmonary Arterial Hypertension

By Dr. Jeremy Feldman

Diet Pills and Methamphetamines Stimulants were first suspected of causing pulmonary hypertension in the late 1960’s

good news in pah

 

Disclaimer

Recent Blog Posts

  • New PAH Drug Ralinepag Shows Exciting Results in Major Study October 18, 2026
  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025

Categories

Archives